Lensar Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Lensar Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010907
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lensar Inc (Lensar), a subsidiary of Alphaeon Corp is a medical device company that designs, develops and manufactures laser and advanced 3D imaging technology and devices for refractive cataract surgery. The company provides surgeon with superior femtosecond laser technology. It offers various technologies such as LENSAR laser system, augmented reality and smart corneal incisions. Lensar’s laser system fs 3D (LLS-fs 3D) is used during cataract surgery for removal of the crystalline lens. The company’s augmented reality, a reconstructed 3-D imaging, measurement and guidance system provides high-resolution ocular images in a single scan. It also provides practice support and clinical training services. Lensar is headquartered in Orlando, Florida, the US.

Lensar Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lensar Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Lensar Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Lensar Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Lensar Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Lensar Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Lensar Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Lensar (LaserSoft Vision) Secures USD16 Million in Venture Funding 10
LensAR Raises USD8 Million in Venture Financing 11
LensAR Raises US$10 Million In Venture Financing 12
LensAR Raises US$17.4 Million In Venture Financing 13
LensAR Raises US$5 Million In Venture Financing 14
LensAR Raises US$24 Million In Series F Financing Round 15
LensAR Secures US$1.4 Million In Venture Financing 16
LensAR Secures US$5 Million In Venture Financing 17
LensAR Secures US$2 Million In Financing Round 18
Private Equity 19
LensAR Completes US$27 Million In Private Equity Financing 19
Acquisition 20
Alphaeon Acquires LENSAR for USD59 Million 20
Topcon Europe Medical Invests US$4 Million In LensAR 21
Lensar Inc – Key Competitors 22
Lensar Inc – Key Employees 23
Lensar Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Corporate Communications 25
Nov 08, 2017: Ophthalmic Industry Leader William J. Link, Ph.D., Joins LENSAR Board of Directors as Chairman 25
Legal and Regulatory 26
Dec 19, 2016: Lensar Strategic Restructure In Partnership With Pdl Biopharma
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Lensar Inc, Medical Equipment, Key Facts 2
Lensar Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Lensar Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Lensar Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Lensar Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Lensar Inc, Deals By Market, 2011 to YTD 2017 8
Lensar Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Lensar (LaserSoft Vision) Secures USD16 Million in Venture Funding 10
LensAR Raises USD8 Million in Venture Financing 11
LensAR Raises US$10 Million In Venture Financing 12
LensAR Raises US$17.4 Million In Venture Financing 13
LensAR Raises US$5 Million In Venture Financing 14
LensAR Raises US$24 Million In Series F Financing Round 15
LensAR Secures US$1.4 Million In Venture Financing 16
LensAR Secures US$5 Million In Venture Financing 17
LensAR Secures US$2 Million In Financing Round 18
LensAR Completes US$27 Million In Private Equity Financing 19
Alphaeon Acquires LENSAR for USD59 Million 20
Topcon Europe Medical Invests US$4 Million In LensAR 21
Lensar Inc, Key Competitors 22
Lensar Inc, Key Employees 23

★海外企業調査レポート[Lensar Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PNE Wind AG (PNE3):電力:M&Aディール及び事業提携情報
    Summary PNE Wind AG (PNE) is a renewable energy company, which develops onshore and offshore wind farms. It has a presence in the wind energy value chain, from site exploration and implementation of approval procedure, financing and turnkey construction to operation and repowering. The company also …
  • Serinus Energy plc (SEN):企業の財務・戦略的SWOT分析
    Summary Serinus Energy plc (Serinus), formerly Serinus Energy Inc, is an oil and gas company. It carries out exploration, development, and production of crude oil and natural gas assets in Romania and Tunisia. The company holds interest and operates Satu Mare Concession, an oil and gas exploration b …
  • Richter Gedeon Nyrt (RICHTER):医療機器:M&Aディール及び事業提携情報
    Summary Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological …
  • China Railway Signal & Communication Corp Ltd:企業の戦略・SWOT・財務情報
    China Railway Signal & Communication Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Signal & Communication Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Caribbean Utilities Company, Ltd.:発電所・企業SWOT分析
    Caribbean Utilities Company, Ltd. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • American Woodmark Corp (AMWD):企業の財務・戦略的SWOT分析
    American Woodmark Corp (AMWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Terumo Cardiovascular Systems Corp:企業の戦略的SWOT分析
    Terumo Cardiovascular Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Leap Therapeutics Inc (LPTX)-医療機器分野:企業M&A・提携分析
    Summary Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that acquires, develops novel therapeutics for cancer research. The company’s pipeline encompasses DKN-01, a humanized monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, and in clinical tria …
  • Oxeia Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxeia Biopharmaceuticals Inc (Oxeia Biopharmaceuticals) is a clinical stage biotech company that develops drug treatments for mild traumatic brain injury or concussion and underlying neuro-metabolic dysfunction. The company’s lead pipeline candidate includes OXE-103, potent mitochondrial sta …
  • Iridex Corp (IRIX):企業の財務・戦略的SWOT分析
    Summary Iridex Corp (Iridex) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company offers products such as lasers, laser delivery devices, glaucoma device …
  • Medizone International Inc (MZEI):企業の財務・戦略的SWOT分析
    Summary Medizone International Inc (Medizone) is a medical device company that develops aseptic treatment. The company provides disinfectant products used in surgical and other medical treatment facilities. Its product includes AsepticSure hospital sterilization system. Medizone’s AsepticSure is an …
  • Pure Technologies Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Pure Technologies Ltd. (Pure Technologies) develops technologies for inspection, monitoring and management of physical infrastructure such as buildings, water and hydrocarbon pipelines, and bridges. It provides proprietary monitoring equipment for pipelines, bridges and structures; technical …
  • NeoGenomics Inc (NEO):企業の財務・戦略的SWOT分析
    Summary NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immuno …
  • Jumboking Foods Pvt. Ltd.
    Jumboking Foods Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Jumboking Foods Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • United Utilities Group Plc (UU):電力:M&Aディール及び事業提携情報
    Summary United Utilities Group PLC (United Utilities) is a provider of water and wastewater services. It gathers water from reservoirs, lakes, boreholes and streams; and collects and treats wastewater, and deposits it into rivers and sea. The company extracts water from Lake Vyrnwy in Wales for cust …
  • Valneva SE (VLA):製薬・医療:M&Aディール及び事業提携情報
    Summary Valneva SE (Valneva) is a biotech company that develops lifesaving vaccines. The company’s products include IXIARO, a vaccine indicated for the prevention of Japanese encephalitis; and Dukoral, a vaccine indicated for the prevention of cholera and diarrhea; clostridium difficile, lyme, chiku …
  • University of California Irvine-製薬・医療分野:企業M&A・提携分析
    Summary University of California Irvine (UCI), a subsidiary of University of California is an educational university that provides undergraduate and graduate degree courses and research services. The university provides educational courses in various fields such as business, education, engineering, …
  • Toma Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Toma Biosciences Inc (Toma Biosciences) is a provider of genome sequencing solutions. The company launched TOMA OS-Seq cancer assay to laboratories and researchers for the changes in tumors. Its products include reagent kits that are developed to detect genomic changes in cancer and TOMA OS- …
  • Petro Matad Ltd (MATD):企業の財務・戦略的SWOT分析
    Summary Petro Matad Ltd (Petro Matad) is an oil and gas company that develops and operates oil and gas exploration properties. The company’s upstream oil and gas exploration asset base includes Block IV, Block XX, and Block V. Its Block XX is located in the far eastern part of Mongolia producing oil …
  • Kier Group Plc (KIE):企業の財務・戦略的SWOT分析
    Kier Group Plc (KIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆